BUSINESS Aurobindo Pharma’s CuraTeQ Biologics receives Health Canada nod for Bevqolva biosimilar May 1, 2026
BUSINESS Aurobindo Pharma receives USFDA approval for Dextromethorphan Polistirex suspension Apr 17, 2026
BUSINESS Aurobindo Pharma receives USFDA approval for Glycerol Phenylbutyrate Oral Liquid Apr 17, 2026
Stocks to watch on brokerages today, April 16: Aurobindo Pharma, Adani Enterprises, HAL, ICICI Lombard in focus Apr 16, 2026
Aurobindo Pharma subsidiary to invest up to USD 175 million in new manufacturing facility Apr 15, 2026
Top stocks for trade today, April 8: Aurobindo Pharma, Lupin, Angel One, Infosys, PB Fintech and more Apr 8, 2026
Aurobindo Pharma secures USFDA approval for diabetes drug with estimated market size of $514 million Apr 7, 2026
Aurobindo Pharma receives USFDA approval for Dapagliflozin tablets with market size of $10.2 billion Apr 7, 2026
Top stocks for trade today, April 7: Godrej Consumer Products, Kalyan Jewellers, IRFC, Aurobindo Pharma and more Apr 7, 2026
Aurobindo Pharma’s CuraTeQ Biologics announces positive results for omalizumab biosimilar study Apr 6, 2026
Aurobindo Pharma subsidiary CuraTeQ Biologics enters EU biosimilars agreement with STADA Mar 25, 2026
Aurobindo Pharma’s subsidiary facility classified as ‘Voluntary Action Indicated’ by US FDA Mar 20, 2026